NIKA — Nika Pharmaceuticals Cashflow Statement
0.000.00%
- $972.93m
- $973.18m
- 26
- 22
- 43
- 20
Annual cashflow statement for Nika Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.009 | -0.015 | -3.18 | -0.065 | -0.096 |
Non-Cash Items | — | 0 | 3.15 | 0 | -0.043 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | — | — | — | — | -0.016 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.018 | -0.029 | -0.067 | -0.13 | -0.31 |
Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | 0 | 0 | 0 | — |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.021 | 0.027 | 0.068 | 0.167 | 0.275 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.002 | -0.001 | 0 | 0.019 | -0.018 |